China Approves First Recombinant Botulinum Toxin for Glabellar Lines
The neurotoxin, developed by Claruvis Pharmaceutical, uses a precision-engineered recombinant manufacturing process for botulinum toxin type A.
Tag: recombinant botulinum toxic
All
Popular
All
LatestSorry, No Posts Found
All
Latest
Galderma’s Relfydess Approved in China for Treatment of Frown Lines
The ready-to-use liquid botulinum toxin treatment requires no reconstitution. Phase III trials showed improvements in frown lines, with some patients maintaining results for up to six months.
